Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period

Journal of Clinical Microbiology

Volumn 36, Issue 11, 1998, Pages 3303-3308

  Thal, Leeann ^a,b,c   Donabedian, Susan ^a,b,c   Robinson Dunn, Barbara ^d,e   Chow, Joseph W ^a,b,f   Dembry, Louise ^a,b,g   Clewell, Don B ^a,h   Alshab, Drew ^d,e   Zervos, Marcus J ^a,c,f  

^a Department of Medicine ^*  (United States)

^b Departments of Infectious Disease   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d Sect Microbiol and Dis Survlnc   (United States)

^e MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHROMOSOME; ENTEROCOCCUS FAECALIS; GENE; HOSPITAL; HYBRIDIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; POSIBACTERIA; PROKARYOTA; STREPTOCOCCUS;

EID: 0031720334     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.11.3303-3308.1998     Document Type: Article

References (29)

1. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
2. Ausubel, F. M. et al. (ed.). 1993. Current protocols in molecular biology, vol. 1, unit 2.4. John Wiley and Sons, Inc., New York, N.Y.
3. Bonten, M., S. Slaughter, M. Hayden, C. Nathan, J. V. Voorhis, T. Rice, and R. A. Weinstein. 1996. Patients' endogenous flora as a source of "nosocomial" vancomycin-resistant enterococci (VRE). In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, 15 to 17 September 1996, New Orleans, La. The American Society for Microbiology, Washington, D.C.
4. Boyce, J. M., S. M. Opal, J. W. Chow, M. J. Zervos, G. Potter-Bynoe, C. B. Sherman, R. L. C. Romulo, S. Fortna, and A. A. Medeiros. 1994. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 32:1148-1153.
5. Centers for Disease Control. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
6. Centers for Disease Control. 1997. National nosocomial infection surveillance system report. May 1997. Centers for Disease Control, Atlanta, Ga.
7. Chow, J. E., A. Kuritza, D. M. Shlaes, M. Green, D. F. Sahm, and M. J. Zervos. 1993. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J. Clin. Microbiol. 31:1609-1611.
8. Coque, T. M., R. C. Ardnino, and B. E. Murray. 1995. High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clin. Infect. Dis. 20:1048-1051.
9. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37:2311-2317.
10. Dembry, L. M., L. A. Thal, and M. J. Zervos. 1993. Molecular characterization of a novel glycopeptide resistance phenotype in E. faecium. In Proceedings of the 93rd General Meeting of the American Society for Microbiology, May 1993. American Society for Microbiology, Washington, D.C.
11. Dembry, L. M., K. Uzokwe, and M. J. Zervos. 1996. Control of endemic glycopeptide-resistant enterococci. Infect. Control Hosp. Epidemiol. 17:286-292.
12. Donabedian, S. M., J. W. Chow, J. M. Boyce, R. E. McCabe, S. M. Markowitz, P. E. Coudron, A. Kuritz, C. L. Pierson, and M. J. Zervos. 1992. Molecular typing of ampicillin-resistant, non-β-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J. Clin. Microbiol. 30: 2757-2761.
13. Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27:731-734.
14. Frieden, T. R., S. S. Munsiff, D. E. Low, et al. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79.
15. Gold, H. S., S. Unal, E. Cercenado, C. Thauvin-Eliopoulos, G. M. Eliopoulos, C. B. Wennersten, and R. C. Moellering, Jr. 1993. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob. Agents Chemother. 37:1604-1609.
16. Handwerger, S., B. Raucher, D. Altarac, et al. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin. Infect. Dis. 16:750-753.
17. Handwerger, S., J. Skoble, L. F. Discotto, and M. Pucci. 1995. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the north-eastern United States. Antimicrob. Agents Chemother. 39:362-368.
18. Hayden, M. K., G. M. Trenholme, J. E. Schultz, and D. F. Sahm. 1993. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J. Infect. Dis. 167:1224-1227.
19. Jarvis, W. R., and W. J. Marton. 1992. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29(Suppl. A):19-24.
20. Jensen, L. B., P. Ahrens, L. Dons, R. N. Jones, A. M. Hammerum, and F. M. Aarestrup. 1998. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J. Clin. Microbiol. 36:437-442.
21. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
22. Morena, F., P. Grota, C. Crisp, K. Magnon, G. P. Melcher, J. H. Jorgensen, and J. E. Patterson. 1995. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in Southern Texas. Clin. Infect. Dis. 21:1234-1237.
23. National Committee for Clinical Laboratory Standards. 1994. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Sader, H. S., M. A. Tenover, F. C. Hollis, R. J. Jones, and R. N. Jones. 1994. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J. Clin. Microbiol. 32:2840-2842.
25. Schaberg, D. R. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72S-75S.
26. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
27. Van der Auwera, P., N. Pensart, V. Korten, B. E. Murray, and R. Leclercq. 1996. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J. Infect. Dis. 173: 1129-1136.
28. Witte, W., and I. Klare. 1995. Glycopeptide-resistant Enterococcus faecium outside hospitals: a commentary, Microbiol. Drug Resist. 3:259-263.
29. Zervos, M. J., C. A. Kauffman, P. M. Therasse, A. G. Bergman, T. S. Mikesell, and D. R. Schaberg. 1987. Nosocomial infection by gentamicin resistant Streptococcus faecalis: an epidemiologic study. Ann. Intern. Med. 106:687-691.